HOTH News and Press, Hoth Therapeutics Inc. From 08/13/20

NEW YORK , Aug. 13, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that it has submitted for ethics approval in Australia for its planned Clinical study of its therapeutic BioLexa for Atopic Dermatitis. The e...

NEW YORK, NY / ACCESSWIRE / August 10, 2020 / Hoth Therapeutics, Inc. (NASDAQ:HOTH), a biopharmaceutical company, announced today that the Company would be presenting at LD Micro's Zooming with LD on Tuesday, August 11th, 2020. Robb Knie, Chief Executive Officer, will be presenting an ove...

Hoth Therapeutics (NASDAQ: HOTH )   jumps 25%  premarket on its announcement of licensing IP rights to develop real-time mobile testing device that has the potential to immediately diagnose COVID-19 infection through breath sample. More news on: Hoth Therapeutics, Inc., H...

Seres Therapeutics (NASDAQ: MCRB ) +266%  on success of lead drug in C. diff study. More news on: Seres Therapeutics, Inc., Trevena, Inc., Hoth Therapeutics, Inc., Stocks on the move, , Read more ...

NEW YORK , Aug. 10, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced licensing the intellectual property rights relating to the development of a medical device that has the potential to allow public health professionals to...

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. "For the first time in ten years, we were unable to host our mid-year conference, which ...

Hoth Therapeutics ( HOTH +11.4% ) inks an agreement with Isoprene, a University of Maryland, Baltimore New Venture Initiative startup, for the rights to VNLG-152, a novel retinamide, a retinoic acid metabolism block agent or RAMBA, for use in dermatology. More news on: Hoth Therapeutic...

NEW YORK , July 31, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has executed a licensing agreement with Isoprene Pharmaceuticals, Inc. to acquire the rights to VNLG-152, a novel retinamides (Retinoic acid...

Over 100 Presenting Companies Have Already Registered NEW YORK, NY / ACCESSWIRE / July 30, 2020 / Sidoti, among the preeminent providers of independent securities research to small- and micro-cap companies with about 200 names under coverage, is pleased to announce that its Fall 2020 Vi...

NEW YORK , July 09, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. (the Company) announced today it has retained Buenaventura Advisors, LLC to explore strategic alternatives for HaloVax, a biopharmaceutical company and special purpose subsidiary of Voltron Therapeutics, Inc.  ...